MAPK1 and depressive disorder: Increasing evidence supported a pivotal role of the mitogen-activated protein kinase (MAPK) in the pathogenesis, symptomatology, and treatment of depression, in particular the extracellular signal-regulated kinase (ERK) subclass of MAPKs [54].